Horvath Keith A, Ferguson T Bruce, Guyton Robert A, Edwards Fred H
National Heart, Lung, Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Ann Thorac Surg. 2005 Dec;80(6):2082-5. doi: 10.1016/j.athoracsur.2005.06.020.
For sole therapy transmyocardial laser revascularization (TMR), unstable angina has been demonstrated to be a significant independent predictor of operative mortality. The objective of this study was to investigate the preoperative risk profile of patients undergoing TMR plus coronary artery bypass graft surgery (CABG) and to determine the impact of unstable angina on outcomes.
Using The Society of Thoracic Surgeons National Cardiac Database from 1998 to 2003, 5,618 patients underwent TMR plus CABG. These patients were compared with 932,715 patients who underwent CABG only operations.
The TMR plus CABG patients had a significantly higher incidence of diabetes (50% versus 34%), renal failure (7% versus 5%), peripheral vascular disease (20% versus 16%), reoperative surgery (26% versus 9%), three-vessel coronary artery disease (80% versus 71%), hyperlipidemia (73% versus 62%; p < 0.001 for all comparisons). The incidence of preoperative unstable angina was similar (46% versus 47%). The unadjusted perioperative mortality was 3.8% for TMR plus CABG patients. When unstable angina patients were removed, the observed mortality for TMR plus CABG was decreased to 2.7%.
It is likely that patients who undergo TMR plus CABG have a higher prevalence of diffuse coronary disease based on their preoperative demographics. Despite the increased risk associated with such anatomy, the mortality rate was not significantly increased when TMR was added to CABG in an effort to provide a more complete revascularization. As was noted from the outcomes of sole therapy TMR, in unstable angina patients, TMR plus CABG carries a higher risk, but this risk is not significantly different from that of such patients treated with CABG alone.
对于经皮心肌激光血运重建术(TMR)单一治疗,不稳定型心绞痛已被证明是手术死亡率的重要独立预测因素。本研究的目的是调查接受TMR加冠状动脉旁路移植术(CABG)患者的术前风险概况,并确定不稳定型心绞痛对手术结果的影响。
使用1998年至2003年胸外科医师协会国家心脏数据库,5618例患者接受了TMR加CABG。将这些患者与仅接受CABG手术的932715例患者进行比较。
TMR加CABG患者的糖尿病发病率显著更高(50%对34%)、肾衰竭(7%对5%)、外周血管疾病(20%对16%)、再次手术(26%对9%)、三支冠状动脉疾病(80%对71%)、高脂血症(73%对62%;所有比较p<0.001)。术前不稳定型心绞痛的发病率相似(46%对47%)。TMR加CABG患者未调整的围手术期死亡率为3.8%。去除不稳定型心绞痛患者后,TMR加CABG的观察死亡率降至2.7%。
基于术前人口统计学特征,接受TMR加CABG的患者可能弥漫性冠状动脉疾病的患病率更高。尽管与这种解剖结构相关的风险增加,但为了提供更完全的血运重建,在CABG中加入TMR时死亡率并未显著增加。正如单一治疗TMR的结果所示,在不稳定型心绞痛患者中,TMR加CABG的风险更高,但这种风险与仅接受CABG治疗的此类患者相比无显著差异。